-
January 28, 2022 Psychedelic Business Spotlight — January 28This week in psychedelic business news: A major player begins manufacturing; another rebrands; and one...
-
January 26, 2022 MindMed gets FANTASTIC News from the FDA, Causing its Stock to Skyrocket (MNMD/MMED) | Project LucyFollow us on Twitter: @Psy_Invest @psy_holy @PsycSpotlight Follow us on Instagram: @thepsychedelicinvestor @psycspotlight To learn...
-
January 22, 2022 Rick Doblin Interview: Psychedelics and the Soviets, A “Driver’s License” to take Drugs, Curing PTSDDonate to MAPS: https://maps.org/about-maps/our-team/ Follow us on Twitter: @Psy_Invest @psy_holy @PsycSpotlight Follow us on Instagram:...
-
January 21, 2022 Psychedelic Business Spotlight – January 21Catch up on some of the biggest psychedelic business developments that unfolded in the last...
-
January 18, 2022 Cybin Set to Measure Psychedelic Effects on the Brain Using Kernel Flow’s Revolutionary TechnologyThe technology may be more broadly used in the future for neuroscientific or physiological studies...
-
January 15, 2022 Can Next Generation Psychedelics Treat Mental Illness? | Mindset Pharma | DMT, 5-MEO-DMTIn today’s episode of the Psychedelic Spotlight Podcast, The Psychedelic Investor sits down with James...
-
January 14, 2022 Psychedelic Business Spotlight — January 14This week in psychedelic business news: Another psychedelics company starts trading on OTCQB; another ketamine...
-
January 13, 2022 Can DMT Treat Depression?Welcome to the Psychedelic Spotlight podcast. In this episode, the Psychedelic Investor sits down with...
-
January 7, 2022 Interview with James Lanthier, CEO of Mindset PharmaCEO of Mindset Pharma, James Lanthier, gives us an overview of his company and the...
-
January 7, 2022 Psychedelic Business Spotlight — January 7This week in psychedelic business news: Mindset Pharma partners with global pharmaceutical company; Awakn Life...
